Vyanka Redenbaugh

Apr 9, 2024 | onlinelibrary.wiley.com | Vyanka Redenbaugh |James Fryer |Laura Cacciaguerra |John Chen

Introduction Myelin oligodendrocyte glycoprotein antibody (MOG-IgG) was identified as a biomarker of central nervous system (CNS) demyelinating disease in 2007.1 More recently, MOG-IgG-associated disease (MOGAD) was recognized as a separate disease, distinct from multiple sclerosis (MS) and aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD) with international diagnostic criteria proposed in 2023.2 MOGAD is commonly associated with optic neuritis (ON), acute...

Sep 25, 2023 | n.neurology.org | Laura Cacciaguerra |Vyanka Redenbaugh |John Chen

For assistance, please contact: AAN Members (800) 879-1960 or (612) 928-6000 (International) Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international) Sign Up Information on how to subscribe to Neurology and Neurology: Clinical Practice can be foundPurchase Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00.

Jun 16, 2023 | n.neurology.org | Laura Cacciaguerra |Vyanka Redenbaugh |John Chen |Pearse Morris

REQUIREMENTSYou must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information. Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.